Effect of ACPA IgM Serostatus on Efficacy Outcomes Following Treatment with Abatacept or Adalimumab: A Post Hoc Analysis of a Phase III Head-to-Head Trial

被引：0
|
作者：
Huizinga, Thomas [1 ]
Toes, Rene [1 ]
Weinblatt, Michael [2 ]
Schiff, Michael [3 ]
Fleischmann, Roy [4 ,5 ]
Elbez, Yedid [6 ]
Connolly, Sean [7 ]
Maldonado, Michael [7 ]
Gao, Sheng [7 ]
机构：
[1] Leiden Univ, Med Ctr, Leiden, Netherlands
[2] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA
[3] Univ Colorado, Denver, CO 80202 USA
[4] Metroplex Clin Res Ctr, Dallas, TX USA
[5] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[6] Excelya, Boulogne, France
[7] Bristol Myers Squibb, Princeton, NJ USA
来源：
ARTHRITIS & RHEUMATOLOGY | 2019年 / 71卷
关键词：
SUBCUTANEOUS ABATACEPT; ARTHRITIS;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1425
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Impact of Glucocorticoid Therapy on the Efficacy of SC Abatacept or Adalimumab in RA Patients with Inadequate Response to MTX: A Post Hoc Analysis of Data from a Head-to-Head Trial
    Degboe, Yannick
    Schiff, Michael
    Weinblatt, Michael
    Fleischmann, Roy
    Ahmad, H. A.
    Constantin, Arnaud
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [2] HEAD-TO-HEAD COMPARISON OF SUBCUTANEOUS ABATACEPT VS ADALIMUMAB IN THE TREATMENT OF RHEUMATOID ARTHRITIS: KEY EFFICACY AND SAFETY RESULTS FROM THE AMPLE TRIAL
    Weinblatt, Michael E.
    Schiff, Michael H.
    Fleischmann, Roy
    Valente, Robert
    van der Heijde, Desiree
    Citera, Gustavo
    Zhao, Cathy
    Maldonado, Michael A.
    RHEUMATOLOGY, 2013, 52 : 45 - 46
  • [3] Pharmacodynamic Analysis of Whole Blood Gene Expression over 2 Years in a Phase IIIb Head-to-Head Trial of Abatacept and Adalimumab in Patients with RA
    Jabado, O.
    Maldonado, M. A.
    Schiff, Michael
    Weinblatt, Michael
    Fleischmann, Roy
    Robinson, William H.
    Greenfield, A.
    Connolly, S. E.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [4] Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: two-year efficacy and safety findings from AMPLE trial
    Schiff, Michael
    Weinblatt, Michael E.
    Valente, Robert
    van der Heijde, Desiree
    Citera, Gustavo
    Elegbe, Ayanbola
    Maldonado, Michael
    Fleischmann, Roy
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 (01) : 86 - 94
  • [5] Head-to-Head Comparison of Subcutaneous Abatacept Versus Adalimumab in the Treatment of Rheumatoid Arthritis: Key Efficacy and Safety Results from the AMPLE (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjects with Background Methotrexate) Trial
    Maldonado, Michael
    Weinblatt, Michael
    Schiff, Michael
    Fleischmann, Roy
    Valente, Robert
    Van der Heijde, Desiree
    Citera, Gustavo
    Zhao, Cathy
    JOURNAL OF RHEUMATOLOGY, 2013, 40 (06) : 1005 - 1006
  • [6] Analysis of empagliflozin vs glimepiride by Quality and Outcomes Framework targets: post hoc analysis of a head-to-head study
    Brice, R.
    Spencer, W.
    Asaro-Harris, A.
    Zeller, C.
    Hach, T.
    Salsali, A.
    Naderali, E.
    DIABETIC MEDICINE, 2015, 32 : 95 - 96
  • [7] Efficacy of risankizumab versus ustekinumab by baseline Crohn's Disease location: post-hoc analysis of the SEQUENCE head-to-head trial
    Peyrin-Biroulet, L.
    Colombel, J. F.
    D'Haens, G.
    Dubinsky, M.
    Cao, Q.
    Kligys, K.
    Garrison, A.
    Huang, X.
    Neimark, E.
    Anschutz, T.
    Crowley, J.
    Panaccione, R.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I104 - I105
  • [8] Effect of Adalimumab Treatment on Pruritus: A Post-Hoc Analysis of the Phase III, Randomized REVEAL Trial in Patients with Moderate to Severe Psoriasis
    Kimball, A. B.
    Sundaram, M.
    Gu, Y.
    Teixeira, H.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2012, 132 : S66 - S66
  • [9] Effect of adalimumab treatment on pruritus: A post-hoc analysis of the phase III, randomized REVEAL trial in patients with moderate to severe psoriasis
    Kimball, Alexa B.
    Teixeira, Henrique D.
    Sundaram, Murali
    Gu, Yihua
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2013, 68 (04) : AB198 - AB198
  • [10] Body mass index and treatment response to subcutaneous abatacept in patients with psoriatic arthritis: a post hoc analysis of a phase III trial
    McInnes, Iain B.
    Ferraccioli, Gianfranco
    D'Agostino, Maria-Antonietta
    Le Bars, Manuela
    Banerjee, Subhashis
    Ahmad, Harris A.
    Elbez, Yedid
    Mease, Philip J.
    RMD OPEN, 2019, 5 (01):
12345